Integral Health Asset Management, LLC

Holdings History for Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

Symbol: SAGE
Investment type: Equity / Common Stock, par value $0.0001 per share (the "Common Stock")

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2024		-0.37%	$0	0	-200,000	-100%	$14.85	Q2 2024
31 Mar 2024	0.37%	0%	$3,748,000	200,000	0		$18.74	Q1 2024
31 Dec 2023	0.63%	+0.63%	$4,334,000	200,000	+200,000	NEW	$21.67	Q4 2023
30 Sep 2023		-0.49%	$0	0	-80,000	-100%	$14.85	Q3 2023
30 Jun 2023	0.49%	-1%	$3,761,600	80,000	-165,000	-67%	$47.02	Q2 2023
31 Mar 2023	2.1%	-1%	$10,280,200	245,000	-115,000	-32%	$41.96	Q1 2023
31 Dec 2022	3.1%	+0.03%	$13,730,400	360,000	+3,000	+0.84%	$38.14	Q4 2022
30 Sep 2022	2.9%	-0.44%	$13,980,000	357,000	-55,257	-13%	$39.16	Q3 2022
30 Jun 2022	2.7%	+0.67%	$13,316,000	412,257	+101,257	+33%	$32.30	Q2 2022
31 Mar 2022	2.7%	-0.84%	$10,294,000	311,000	-98,000	-24%	$33.10	Q1 2022
31 Dec 2021	4.8%	+1.1%	$17,399,000	409,000	+90,000	+28%	$42.54	Q4 2021
30 Sep 2021	4.1%	+1.2%	$14,135,000	319,000	+95,000	+42%	$44.31	Q3 2021
30 Jun 2021	3.5%	+1.3%	$12,725,000	224,000	+80,000	+56%	$56.81	Q2 2021
31 Mar 2021	3.1%	-1.1%	$10,778,000	144,000	-51,000	-26%	$74.85	Q1 2021
31 Dec 2020	5%	-0.9%	$16,869,000	195,000	-35,000	-15%	$86.51	Q4 2020
30 Sep 2020	4.4%	+0.68%	$14,058,000	230,000	+35,000	+18%	$61.12	Q3 2020
30 Jun 2020	2.5%	+0.32%	$8,108,000	195,000	+25,000	+15%	$41.58	Q2 2020
31 Mar 2020	2.2%	+0.63%	$4,882,000	170,000	+50,000	+42%	$28.72	Q1 2020
31 Dec 2019	3.4%	0%	$8,663,000	120,000	0		$72.19	Q4 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.